FDA Investigator: Cheryl A. Grandinetti
- Cheryl A. Grandinetti first started conducting FDA inspections in 2018, with the last inspection in 2024. Over that time, Cheryl A. Grandinetti has conducted 15 inspections at 15 companies across 15 sites.
Get Cheryl Grandinetti's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Jan L. Brandes, M.D, Nashville | October 2019
Available Now - $199
Cheryl A. Grandinetti
Human Drug Form 483
FDA 483 Novartis Pharmaceuticals, East Hanover | Dec 2018
Available Now - $199
Cheryl A. Grandinetti
Human Drug Form 483
FDA 483 Applied Therapeutics, Inc., New York | 2024
Out-of-stock
Cheryl A. Grandinetti
Human Drugs Form 483
FDA 483 Han C. Phan, M.D., Brookhaven | 2024
Out-of-stock
Cheryl A. Grandinetti
Human Drugs Form 483
FDA 483 Utility Therapeutics, LTD, Altrincham | 2024
Out-of-stock
Cheryl A. Grandinetti
Human Drugs Form 483
FDA 483 Stephen G. Kaler, M.D., Columbus | 2022
Out-of-stock
Cheryl A. Grandinetti
Human Drug Form 483
FDA 483 PPD, Inc., Wilmington | 2019
Out-of-stock
Cheryl A. Grandinetti
Human Drug Form 483
FDA 483 SK Life Science Inc., Paramus | 2019
Out-of-stock
Cheryl A. Grandinetti
Human Drug Form 483
FDA 483 Catalyst Pharmaceutical Inc., Coral Gables | 2018
Out-of-stock
Cheryl A. Grandinetti
Human Drug Form 483
Co-Investigators (18)
- Benton M. Ketron, FDA Investigator
- Kerun Hardeo, FDA Investigator
- Ann B. Borromeo, FDA Investigator
- Craig A. Garmendia, FDA Investigator
- Tawny L. Colling, FDA Investigator
- Geoffrey K. Kilili, FDA Investigator
- Craig T. Rybus, FDA Investigator
- John Dan, FDA Investigator
- Melanie N. Daniels, FDA Investigator
- David L. Chon, FDA Investigator
- Young M. Yoon, FDA Investigator
- Kent A. Conforti, FDA Investigator
- Eileen J. Bannerman, FDA Investigator
- Kassa Ayalew, FDA Investigator
- Nina Yang, FDA Investigator
- Peter R. Lenahan, FDA Investigator
- Richard A. Lyght, FDA Investigator
- Ruth A. Williams, FDA Investigator